SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-041623
Filing Date
2017-06-23
Accepted
2017-06-23 14:57:57
Documents
2
Period of Report
2017-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4334
2 POA DOCUMENT poa.txt EX-24.4A_732979 3383
  Complete submission text file 0001209191-17-041623.txt   9120
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8201 E RIVERSIDE DRIVE BLDG 4, STE 100 AUSTIN TX 78744
Business Address
STECHER MICHAEL (Reporting) CIK: 0001639077 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37347 | Film No.: 17927329